Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation
Clinical trial NCT01225211 · COMPLETED
Trial details
- NCT number
- NCT01225211
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-04-01
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.